BioSpace News Archive

Previous human pharmacokinetic (PK) study showed significantly better PK profile when compared to market leading product

AI-generated target was identified through The Benevolent Platform® and AstraZeneca’s scientific expertise and rich datasets

Genetron Holdings Limited announced that it will release thirteen new research findings at the 21st World Conference on Lung Cancer, which will be held virtually from January 28 to 31.

Achievement Represents a Significant Milestone in the Company’s Commitment to Become Carbon Zero in its Operations by 2040

Itamar Medical Ltd., a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced the appointment of Scott P. Serota to its Board of Directors.

Expands DarioHealth’s multi-condition platform into the $213 billion musculoskeletal market and creates one of the most comprehensive digital health platforms

SQZ Biotechnologies (NYSE: SQZ), a cell therapy company developing novel potential treatments for multiple therapeutic areas, announced today that the Immune Tolerance group leader, Shinu John, PhD, will present new preclinical data from the company’s Tolerizing Antigen Carriers (SQZ™ TACs) platform in an invited talk at the Antigen-Specific Immune Tolerance (ASIT) Digital Summit taking place January 26, 2021

Preliminary results for the full year of 2020: Sales revenue up 34.6 percent; underlying EBITDA margin climbs to 31.7 percent

Through the esophagus, food enters the stomach and mixes with gastric acid, enzymes, and other gastric juices for digestion purpose.

An implantable port is a thin, soft, silicone tube with a small reservoir attached to it. It is generally put under the skin of chest or sometimes in arm.